Literature DB >> 18024933

Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.

V Mallika1, Binita Goswami, Medha Rajappa.   

Abstract

Atherosclerosis is the root cause of the biggest killer of the 21st century. Mechanisms contributing to atherogenesis are multiple and complex. A number of theories-including the role of dyslipidemia, hypercoagulability, oxidative stress, endothelial dysfunction, and inflammation and infection by certain pathogens-have been propounded from time to time explain this complex phenomenon. Recently it has been suggested that atherosclerosis is a multifactorial, multistep disease that involves chronic inflammation at every step, from initiation to progression, and that all the risk factors contribute to pathogenesis by aggravating the underlying inflammatory process. A better understanding of the pathogenesis of atherosclerosis will aid in devising pharmaceutical and lifestyle modifications for reducing mortality resulting from coronary artery disease (CAD).A comprehensive literature search was conducted using the Web sites of the National Library of Medicine (http:// www.ncbl.nlm.nih.gov/) and PubMed Central, the US National Library of Medicine's digital archive of life sciences literature (http:// www.pubmedcentral.nih.gov/). The data were accessed from books and journals in which relevant articles in this field were published. The whole spectrum of coronary artery disease evolves through various events that lead to the formation and progression of atherosclerotic plaque and finally its complications. Atherosclerosis is the culprit behind coronary artery disease, cerebral vascular disease, and peripheral vascular disease. The pathogenic mechanisms are varied and complex. Of late, the role of lipoprotein (a), homocysteine, and inflammation and infection as prime culprits in pathogenesis of CAD is the subject of intense research and debate. The appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework to understand the clinical benefits of newer therapeutic strategies, and a better understanding of pathogenesis aids in formulating preventive and therapeutic strategies in reducing mortality resulting from CAD.An in-depth knowledge of the various pathogenic mechanisms involved in atherosclerosis can help in substantiating the current existing knowledge about the CAD epidemic. This knowledge will help clinicians to better manage the disease, which affects Indians in its most severe form.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024933     DOI: 10.1177/0003319707303443

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  46 in total

1.  Serum hsCRP and procalcitonin levels in dyspeptic patients infected with CagA-positive Helicobacter pylori.

Authors:  Bulur Oktay; Yeniova Abdullah Ozgur; Kucukazman Metin; Ata Naim; Asilturk Zeliha; Yıldız Mehmet; Kefeli Ayse; Basyigit Sebahat; Aktas Bora; Nazlıgul Yasar
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

2.  Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women.

Authors:  Tracy E Crane; Chieri Kubota; Julie L West; Mark A Kroggel; Betsy C Wertheim; Cynthia A Thomson
Journal:  J Nutr       Date:  2011-08-24       Impact factor: 4.798

3.  Molecular biology of atherosclerosis.

Authors:  Elmo Mannarino; Matteo Pirro
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

4.  Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes.

Authors:  Mujde Akturk; Alev Altinova; Ismail Mert; Aylin Dincel; Ayla Sargin; Umran Buyukkagnici; Metin Arslan; Nuri Danisman
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

Review 5.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

6.  Clinical pharmacology and vascular risk.

Authors:  G Silvestrelli; F Corea; S Micheli; A Lanari
Journal:  Open Neurol J       Date:  2010-06-15

7.  Correlation between the levels of circulating adhesion molecules and atherosclerosis in type-2 diabetic normotensive patients: circulating adhesion molecules and atherosclerosis.

Authors:  Alberto Francisco Rubio-Guerra; Hilda Vargas-Robles; Alberto Maceda Serrano; Jose Juan Lozano-Nuevo; Bruno Alfonso Escalante-Acosta
Journal:  Cell Adh Migr       Date:  2009-10-07       Impact factor: 3.405

8.  Evaluation of cardiovascular risk in school children.

Authors:  Lutvo Sporisević; Vjekoslav Krzelj; Adnan Bajraktarević; Elmedina Jahić
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

9.  LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans.

Authors:  Rajvir Singh; Renata Belfort De Aguiar; Sarita Naik; Sheida Mani; Kamal Ostadsharif; Detlef Wencker; Masoud Sotoudeh; Reza Malekzadeh; Robert S Sherwin; Arya Mani
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

10.  The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.

Authors:  Yong Min Chae; Jong Kwon Park
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.